Open AccessAdjuvant therapy for grade 3, deeply invasive endometrioid adenocarcinoma of the uterus
Author(s) -
Michaela Onstad,
J.A. Ducie,
Bryan Fellman,
Nadeem R. AbuRustum,
Mario M. Leitao,
Andrea Mariani,
Francesco Multinu,
Karen H. Lu,
Pamela T. Soliman
Publication year - 2020
Publication title -
international journal of gynecological cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.901
H-Index - 87
eISSN - 1525-1438
pISSN - 1048-891X
DOI - 10.1136/ijgc-2019-000807
Subject(s) - medicine , lymph node , brachytherapy , endometrial cancer , radiation therapy , adenocarcinoma , lymph , oncology , radiology , surgery , cancer , pathology
Patients with grade 3, deeply invasive endometrioid adenocarcinoma are typically managed with primary surgery. The role and type of adjuvant therapy used is controversial. We sought to evaluate the role of adjuvant radiation and/or chemotherapy in women with deeply invasive grade 3 endometrioid tumors.